ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN

The development of immunogen being capable of providing protection against HIV-1 infection and progression is still topical and unsolved challenge. Since HIV-1 demonstrates strong genetic variability, an efficient vaccine should provide protection against a number of various virus strains. Design of...

Full description

Saved in:
Bibliographic Details
Main Authors: A. P. Rudometov, N. B. Andreeva, A. N. Chikaev, N. S. Shcherbakova, O. N. Kaplina, L. I. Karpenko
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2019-02-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/46
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839628846763081728
author A. P. Rudometov
N. B. Andreeva
A. N. Chikaev
N. S. Shcherbakova
O. N. Kaplina
L. I. Karpenko
author_facet A. P. Rudometov
N. B. Andreeva
A. N. Chikaev
N. S. Shcherbakova
O. N. Kaplina
L. I. Karpenko
author_sort A. P. Rudometov
collection DOAJ
description The development of immunogen being capable of providing protection against HIV-1 infection and progression is still topical and unsolved challenge. Since HIV-1 demonstrates strong genetic variability, an efficient vaccine should provide protection against a number of various virus strains. Design of immunogen with capacity to induce broadly neutralizing antibodies to HIV is believed to solve this issue. As distinct from usual antibodies, bNAbs interact with conservative epitopes providing protective immunity to overwhelming majority of HIV strains. Our study aims to construct and analyze antigenic features of polyepitope HIV-immunogen nTBI comprising epitopes recognized by bNAbs. Materials and methods. We used previously designed TBI protein as molecule-carrier and obtained on this basis protein’s modified variant nTBI. It includes epitopes recognized by bNAbs 10E8, 4E10, 2F5, as well as linear mimetic of conformation epitope bNAb VRC01. Immunoblotting was used to analyze antigenic properties of epitopes in composition of nTBI. To purify nTBI, we used metal chelate chromatography. To study immunogenic properties, we immunized rabbits with purified nTBI preparation. Specific activity of sera from immunized rabbits was identified using ELISA. Affine chromatography on protein A was used to obtain IgG from sera of rabbits. Virus-neutralizing activity of purified IgG was detected in neutralization test using recombinant virus HIV-1 92BR025. Results. Immunogen nTBI comprising epitopes recognized by bNAbs was constructed. We obtained protein nTBI producer providing production of target protein up to 30 % of the amount of producer cell proteins. We showed that in the context of nTBI protein linear epitopes retain their antigenic properties. When immunizing rabbits, we found nTBI inducing production of antibodies capable of neutralizing recombinant HIV-1 strain 92BR025. Conclusion. We demonstrated principal possibility of the use of artificial TBI protein as a scaffold molecule to expose epitopes recognized by broadly neutralizing antibodies.
format Article
id doaj-art-bcb2373aa3b744fb8fd1ba356d1a0033
institution Matheson Library
issn 2410-2512
2410-2520
language Russian
publishDate 2019-02-01
publisher Russian Academy of Sciences, Siberian Branch Publishing House
record_format Article
series Сибирский научный медицинский журнал
spelling doaj-art-bcb2373aa3b744fb8fd1ba356d1a00332025-07-15T11:26:34ZrusRussian Academy of Sciences, Siberian Branch Publishing HouseСибирский научный медицинский журнал2410-25122410-25202019-02-01384374310.15372/SSMJ2018040546ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGENA. P. Rudometov0N. B. Andreeva1A. N. Chikaev2N. S. Shcherbakova3O. N. Kaplina4L. I. Karpenko5State Research Center of Virology and Biotechnology «Vector» of RospotrebnadzorState Research Center of Virology and Biotechnology «Vector» of RospotrebnadzorInstitute of Molecular and Cell Biology of SB RASState Research Center of Virology and Biotechnology «Vector» of RospotrebnadzorState Research Center of Virology and Biotechnology «Vector» of RospotrebnadzorState Research Center of Virology and Biotechnology «Vector» of RospotrebnadzorThe development of immunogen being capable of providing protection against HIV-1 infection and progression is still topical and unsolved challenge. Since HIV-1 demonstrates strong genetic variability, an efficient vaccine should provide protection against a number of various virus strains. Design of immunogen with capacity to induce broadly neutralizing antibodies to HIV is believed to solve this issue. As distinct from usual antibodies, bNAbs interact with conservative epitopes providing protective immunity to overwhelming majority of HIV strains. Our study aims to construct and analyze antigenic features of polyepitope HIV-immunogen nTBI comprising epitopes recognized by bNAbs. Materials and methods. We used previously designed TBI protein as molecule-carrier and obtained on this basis protein’s modified variant nTBI. It includes epitopes recognized by bNAbs 10E8, 4E10, 2F5, as well as linear mimetic of conformation epitope bNAb VRC01. Immunoblotting was used to analyze antigenic properties of epitopes in composition of nTBI. To purify nTBI, we used metal chelate chromatography. To study immunogenic properties, we immunized rabbits with purified nTBI preparation. Specific activity of sera from immunized rabbits was identified using ELISA. Affine chromatography on protein A was used to obtain IgG from sera of rabbits. Virus-neutralizing activity of purified IgG was detected in neutralization test using recombinant virus HIV-1 92BR025. Results. Immunogen nTBI comprising epitopes recognized by bNAbs was constructed. We obtained protein nTBI producer providing production of target protein up to 30 % of the amount of producer cell proteins. We showed that in the context of nTBI protein linear epitopes retain their antigenic properties. When immunizing rabbits, we found nTBI inducing production of antibodies capable of neutralizing recombinant HIV-1 strain 92BR025. Conclusion. We demonstrated principal possibility of the use of artificial TBI protein as a scaffold molecule to expose epitopes recognized by broadly neutralizing antibodies.https://sibmed.elpub.ru/jour/article/view/46bnabs
spellingShingle A. P. Rudometov
N. B. Andreeva
A. N. Chikaev
N. S. Shcherbakova
O. N. Kaplina
L. I. Karpenko
ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
Сибирский научный медицинский журнал
bnabs
title ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
title_full ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
title_fullStr ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
title_full_unstemmed ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
title_short ANTIGENIC PROPERTIES OF ARTIFICIAL POLYEPITOPE HIV IMMUNOGEN
title_sort antigenic properties of artificial polyepitope hiv immunogen
topic bnabs
url https://sibmed.elpub.ru/jour/article/view/46
work_keys_str_mv AT aprudometov antigenicpropertiesofartificialpolyepitopehivimmunogen
AT nbandreeva antigenicpropertiesofartificialpolyepitopehivimmunogen
AT anchikaev antigenicpropertiesofartificialpolyepitopehivimmunogen
AT nsshcherbakova antigenicpropertiesofartificialpolyepitopehivimmunogen
AT onkaplina antigenicpropertiesofartificialpolyepitopehivimmunogen
AT likarpenko antigenicpropertiesofartificialpolyepitopehivimmunogen